Financhill
Back

Aboitiz Equity Ventures Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
50

ABTZY
Aboitiz Equity Ventures

Last Price:
8.17
Seasonality Move:
-8.74%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
38.01
Seasonality Move:
3.65%
Sell
50
Aboitiz Equity Ventures (ABTZY) is a Sell

Is Aboitiz Equity Ventures a Buy, Sell or Hold?

  • The current Aboitiz Equity Ventures [ABTZY] share price is $8.17. The Score for ABTZY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ABTZY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABTZY Stock Price Chart

What is Aboitiz Equity Ventures's stock price today?

  • The Aboitiz Equity Ventures share price today is $8.17
    The current trend is relatively stagnant and ABTZY is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ABTZY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.17 - 8.17) Sell
Bollinger Bands (100): (8.17 - 8.17) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

ABTZY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.17 Sell
20-day SMA: 8.17 Sell
50-day SMA: 8.17 Sell
200-day SMA: 8.71 Sell
8-day EMA: 8.17 Sell
20-day EMA: 8.17 Sell
50-day EMA: 8.19 Sell
200-day EMA: 8.79 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Aboitiz Equity Ventures Earnings Growth & ABTZY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Aboitiz Equity Ventures Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):